ALERJE, INC.

DETROIT, MI · Founded 2019 · Medtech · Private

Digital platform with integrated smart epinephrine auto-injector case and smartphone app for monitoring and managing food allergy oral immunotherapy treatment adherence

Claim this profile

Follows are private to you and power your alerts

Updated · alerje.com

Sector
Medtech
Headquarters
DETROIT, MI
Founded
2019
Latest Form D
$1.9M, Aug 2023
Total capital
$3.5M
Federal grants
$1.5M
3 awards · 2021–2023
Rank in peer group#220 of 477
Private capital raised
$2M
2 Form D · last Aug 2023
39 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
5
7 pending · first 2021
Rank in peer group#57 of 477

Capital timeline

2020202120222023FEDERAL ↑EQUITY ↓Cumulative $3.5M$255K$1.2M$75K1st Form D$75K2nd Form D$1.9M
2020202120222023FEDERAL ↑EQUITY ↓Cumulative $3.5M$255K$1.2M$75K1st Form D$75K2nd Form D$1.9M

Latest events

  • Federal grantDefense · Phase I · Ann Innovative Emergency Medical Tool For The Opioid Epidemic Powered By Artificial Intelligence$75K
  • Federal grantNSF · Phase II · SBIR Phase II: A digital platform to support food allergy oral immunotherapy treatments$1.2M
  • Private capital raisedForm D · SEC · 2nd filing$1.9M
  • Federal grantNSF · Phase I · SBIR Phase I: Food Allergy Management Platform$255K
  • Private capital raisedForm D · SEC · 1st filing$75K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grants#220 · top 46%
  • Granted patents#57 · top 12%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Javier EvelynResearcherExecutive Officer, DirectorLinked by 5 patents · $1.5M in grants as PI
  • Patti GlazaDirectorNamed in SEC Form D filings

What it has protected

USPTO · 5 granted of 12
Show all 12 patent records
  • System And Method For Monitoring And Managing Patients Undergoing ImmunotherapyOct 23, 2025 · Application 19254860Pending
  • Detachable Medical Device SystemAug 19, 2025 · US 12,390,592Granted
  • System And Method For Monitoring And Managing Patients Undergoing ImmunotherapyAug 5, 2025 · US 12,380,979Granted
  • Auto-injection Medical Device SystemFeb 4, 2025 · US 12,214,165Granted
  • Method For Predicting Adverse Symptoms To ImmunotherapyMay 16, 2024 · Application 18505735Pending
  • Detachable Medical Device SystemAug 29, 2023 · US 11,738,149Granted
  • Detachable Medical Device SystemMay 18, 2021 · US 11,007,321Granted
  • System And Method For Monitoring And Managing Patients Undergoing ImmunotherapyApplication PCTUS2021041848Pending
  • Method For Predicting Adverse Symptoms To Food IngestionApplication 63424579Pending
  • System And Method For Monitoring And Managing Patients Undergoing ImmunotherapyApplication 63122049Pending
  • System And Method For Monitoring And Managing Patients Undergoing ImmunotherapyApplication 63052724Pending
  • Auto-injection Medical Device SystemApplication PCTUS2019049483Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .